Get Connected:


Latest News

Trending News Today: New Budget Bill Won't Stabilize the ACA
Top news of the day from across the health care landscape.
A look at last week's top stories in the world of pharmacy.
Exactly how depression affects heart health remains unclear.
Airline passengers can catch the flu from contaminated surfaces such as tray tables, seat belts, and lavatory handles.
Top news of the day from across the health care landscape.
Diabetic retinopathy is the leading cause of blindness among adults aged 20 to 74 years in the US.
Biosimilars for rituximab, trastuzumab, and bevacizumab are currently approved for use in the European Union.
Top news of the day from across the health care landscape.
View More >

From the Journals

New proposed rules for the Medicare Part D drug program could affect the manner in which pharmacy benefit managers administer the program and could impact profitability.
Healthcare stakeholders must evaluate how to use resources more efficiently as it has become clear that driving down prices in one segment of care has not improved medical outcomes for the majority of patients.
This cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
An estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Focusing on cost alone could diminish the vital service aspects behind successfully caring for a patient in a specialty pharmacy.
Upcoming Partner Events